Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CBRL
|
Jody L Bilney |
BUY
Grant, award, or other acquisition
|
Direct | 2,938 Added 32.15% |
-
|
Nov 21
2024 |
|
CBRL
|
Meg Crofton |
BUY
Grant, award, or other acquisition
|
Direct | 2,938 Added 22.84% |
-
|
Nov 21
2024 |
|
CBRL
|
Gilbert Raymond Davila |
BUY
Grant, award, or other acquisition
|
Direct | 2,938 Added 26.77% |
-
|
Nov 21
2024 |
|
CBRL
|
John W Garratt |
BUY
Grant, award, or other acquisition
|
Direct | 2,938 Added 39.27% |
-
|
Nov 21
2024 |
|
GMED
|
David D Davidar |
SELL
Open market or private sale
|
Indirect | 13,254 Reduced 0.0% |
$1,126,590
$85.0 p/Share
|
Nov 21
2024 |
|
GMED
|
David D Davidar |
SELL
Open market or private sale
|
Direct | 13,234 Reduced 2.47% |
$1,124,890
$85.0 p/Share
|
Nov 21
2024 |
|
TRST
|
Thomas O Maggs |
SELL
Sale (or disposition) back to the issuer
|
Direct | 739 Reduced 4.23% |
$27,173
$36.77 p/Share
|
Nov 21
2024 |
|
TRST
|
Thomas O Maggs |
BUY
Exercise of conversion of derivative security
|
Direct | 739 Added 4.06% |
-
|
Nov 21
2024 |
|
AUPH
|
Jill Leversage
Director |
BUY
Grant, award, or other acquisition
|
Direct | 12,135 Added 32.63% |
-
|
Nov 21
2024 |
|
IBTA
|
Thomas D Lehrman
Director |
SELL
Open market or private sale
|
Indirect | 32,935 Reduced 0.0% |
$2,160,865
$65.61 p/Share
|
Nov 21
2024 |
|
AUPH
|
Karen L. Smith
Director |
BUY
Grant, award, or other acquisition
|
Direct | 12,135 Added 32.85% |
-
|
Nov 21
2024 |
|
ACRV
|
Peter Blume Jensen
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 19,910 Reduced 0.84% |
$128,220
$6.44 p/Share
|
Nov 21
2024 |
|
AN
|
Kimberly Dees
SVP & CAO |
SELL
Open market or private sale
|
Direct | 453 Reduced 97.63% |
$76,973
$169.92 p/Share
|
Nov 21
2024 |
|
YETI
|
Martin Duff
SVP Supply Chain & Operations |
SELL
Payment of exercise price or tax liability
|
Direct | 701 Reduced 2.49% |
$26,988
$38.5 p/Share
|
Nov 21
2024 |
|
APP
|
Kkr Denali Holdings L.P. |
SELL
Open market or private sale
|
Indirect | 5,274,246 Reduced 0.0% |
$1,680,638,487
$318.65 p/Share
|
Nov 21
2024 |
|
APP
|
Kkr Denali Holdings L.P. |
BUY
Conversion of derivative security
|
Indirect | 5,205,489 Added 0.0% |
-
|
Nov 21
2024 |
|
APP
|
Kkr Denali Holdings L.P. |
SELL
Other acquisition or disposition
|
Indirect | 68,037 Reduced 0.0% |
-
|
Nov 21
2024 |
|
APP
|
Kkr Group Partnership L.P. |
SELL
Open market or private sale
|
Indirect | 5,274,246 Reduced 0.0% |
$1,680,638,487
$318.65 p/Share
|
Nov 21
2024 |
|
APP
|
Kkr Group Partnership L.P. |
BUY
Conversion of derivative security
|
Indirect | 5,205,489 Added 0.0% |
-
|
Nov 21
2024 |
|
APP
|
Kkr Group Partnership L.P. |
SELL
Bona fide gift
|
Indirect | 17,062 Reduced 0.0% |
-
|
Nov 21
2024 |
|
APP
|
Kkr Group Partnership L.P. |
SELL
Other acquisition or disposition
|
Indirect | 68,037 Reduced 0.0% |
-
|
Nov 21
2024 |
|
DV
|
Laura Desmond |
SELL
Open market or private sale
|
Indirect | 37,500 Reduced 0.0% |
$749,250
$19.98 p/Share
|
Nov 21
2024 |
|
DV
|
Laura Desmond |
BUY
Exercise of conversion of derivative security
|
Indirect | 37,500 Added 0.0% |
$75,374
$2.01 p/Share
|
Nov 21
2024 |
|
AUPH
|
Jeffrey Allen Bailey
Director |
BUY
Grant, award, or other acquisition
|
Direct | 12,135 Added 32.25% |
-
|
Nov 21
2024 |
|
GMED
|
Dan Lemaitre |
SELL
Open market or private sale
|
Direct | 13,278 Reduced 100.0% |
$1,128,630
$85.0 p/Share
|
Nov 21
2024 |
|
GMED
|
Dan Lemaitre |
BUY
Exercise of conversion of derivative security
|
Direct | 13,278 Added 50.0% |
$863,733
$65.05 p/Share
|
Nov 21
2024 |
|
JOBY
|
Gregory Bowles
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 11,156 Added 21.64% |
-
|
Nov 21
2024 |
|
MODV
|
L Heath Sampson
President, CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 55 Reduced 0.14% |
$960
$17.47 p/Share
|
Nov 21
2024 |
|
BCOV
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 16,806 Added 0.0% |
$50,418
$3.0 p/Share
|
Nov 21
2024 |
|
AMZN
|
Brian T Olsavsky
Senior Vice President and CFO |
SELL
Open market or private sale
|
Direct | 14,600 Reduced 22.96% |
$2,962,048
$202.88 p/Share
|
Nov 21
2024 |
|
AMZN
|
Brian T Olsavsky
Senior Vice President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 14,600 Added 18.67% |
-
|
Nov 21
2024 |
|
QSR
|
J Patrick Doyle
Executive Chairman |
SELL
Open market or private sale
|
Direct | 42,052 Reduced 24.88% |
$2,918,408
$69.4 p/Share
|
Nov 21
2024 |
|
QSR
|
J Patrick Doyle
Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 106,549 Added 38.66% |
-
|
Nov 21
2024 |
|
AUPH
|
Craig A Johnson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 20,631 Added 50.0% |
-
|
Nov 21
2024 |
|
EGHT
|
Laurence Denny
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 11,227 Reduced 4.06% |
$33,681
$3.0 p/Share
|
Nov 21
2024 |
|
STRS
|
Oasis Management CO Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 373 Reduced 0.0% |
$10,071
$27.0 p/Share
|
Nov 21
2024 |
|
AMRX
|
Deborah M. Autor
Director |
SELL
Open market or private sale
|
Direct | 6,771 Reduced 7.25% |
$56,944
$8.41 p/Share
|
Nov 21
2024 |
|
AMZN
|
David Zapolsky
Senior Vice President |
SELL
Open market or private sale
|
Direct | 11,680 Reduced 16.21% |
$2,335,649
$199.97 p/Share
|
Nov 21
2024 |
|
AMZN
|
David Zapolsky
Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 14,600 Added 16.85% |
-
|
Nov 21
2024 |
|
UFI
|
Albert P Carey
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 3,007 Reduced 1.24% |
$17,290
$5.75 p/Share
|
Nov 21
2024 |
|
AUPH
|
David R.W. Jayne
Director |
BUY
Grant, award, or other acquisition
|
Direct | 12,135 Added 17.68% |
-
|
Nov 21
2024 |
|
GMED
|
Daniel T Scavilla
President, CEO |
SELL
Open market or private sale
|
Direct | 130,000 Reduced 100.0% |
$11,050,000
$85.0 p/Share
|
Nov 21
2024 |
|
GMED
|
Daniel T Scavilla
President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 130,000 Added 50.0% |
$5,678,400
$43.68 p/Share
|
Nov 21
2024 |
|
DV
|
Nicola T Allais
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,274 Reduced 2.71% |
$45,502
$20.01 p/Share
|
Nov 21
2024 |
|
DV
|
Nicola T Allais
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,274 Added 2.64% |
$4,570
$2.01 p/Share
|
Nov 21
2024 |
|
GDYN
|
Leonard Livschitz
CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Indirect | 159 Reduced 0.0% |
$2,815
$17.71 p/Share
|
Nov 21
2024 |
|
FRSH
|
Sameer K Gandhi |
BUY
Conversion of derivative security
|
Indirect | 4,665,040 Added 0.0% |
-
|
Nov 21
2024 |
|
FRSH
|
Sameer K Gandhi |
BUY
Other acquisition or disposition
|
Indirect | 97,229 Added 0.0% |
-
|
Nov 21
2024 |
|
FRSH
|
Sameer K Gandhi |
SELL
Other acquisition or disposition
|
Indirect | 4,665,040 Reduced 0.0% |
-
|
Nov 21
2024 |
|
UFI
|
Meredith Suzanne Boyd
EVP |
SELL
Payment of exercise price or tax liability
|
Direct | 301 Reduced 0.43% |
$1,730
$5.75 p/Share
|
Nov 21
2024 |